Immutep (ASX:IMM) announces positive results in head and neck cancer treatment
Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses the company’s latest results in head and neck cancer. Peter Milios: I’m Peter Milios from the Finance News Network, and today we’re talking with Immutep (ASX:IMM). Immutep is trading under the ASX code “IMM” and has a market capitalisation of approximately $487m. Immutep is a […]
Immutep (ASX:IMM) announces positive results in head and neck cancer treatment Read More »